"RNA-Binding Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA.
Descriptor ID |
D016601
|
MeSH Number(s) |
D12.776.157.725 D12.776.664.962
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "RNA-Binding Proteins".
Below are MeSH descriptors whose meaning is more specific than "RNA-Binding Proteins".
This graph shows the total number of publications written about "RNA-Binding Proteins" by people in this website by year, and whether "RNA-Binding Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 1 | 2 |
1996 | 1 | 1 | 2 |
1997 | 2 | 2 | 4 |
1998 | 1 | 1 | 2 |
1999 | 2 | 2 | 4 |
2000 | 4 | 1 | 5 |
2001 | 1 | 0 | 1 |
2002 | 2 | 2 | 4 |
2003 | 3 | 2 | 5 |
2004 | 4 | 1 | 5 |
2005 | 2 | 0 | 2 |
2006 | 0 | 4 | 4 |
2007 | 2 | 4 | 6 |
2008 | 1 | 4 | 5 |
2009 | 4 | 4 | 8 |
2010 | 2 | 5 | 7 |
2011 | 7 | 3 | 10 |
2012 | 6 | 3 | 9 |
2013 | 7 | 5 | 12 |
2014 | 5 | 4 | 9 |
2015 | 3 | 2 | 5 |
2016 | 6 | 4 | 10 |
2017 | 12 | 5 | 17 |
2018 | 6 | 6 | 12 |
2019 | 5 | 2 | 7 |
2020 | 9 | 6 | 15 |
2021 | 5 | 2 | 7 |
2022 | 0 | 1 | 1 |
2023 | 1 | 6 | 7 |
2024 | 8 | 3 | 11 |
2025 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "RNA-Binding Proteins" by people in Profiles.
-
N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity. RNA. 2025 Feb 19; 31(3):395-401.
-
Hypusinated and unhypusinated isoforms of the translation factor eIF5A exert distinct effects in models of pancreas development and function. J Biol Chem. 2025 Feb; 301(2):108209.
-
YTHDF1 loss in dendritic cells potentiates radiation-induced antitumor immunity via STING-dependent type I IFN production. J Clin Invest. 2024 Dec 02; 134(23).
-
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms. Immunity. 2024 12 10; 57(12):2879-2894.e11.
-
Severe neurodevelopmental phenotype, diagnostic, and treatment challenges in patients with SECISBP2 deficiency. Genet Med. 2024 Dec; 26(12):101280.
-
IGF2BP3 promotes mRNA degradation through internal m7G modification. Nat Commun. 2024 Aug 28; 15(1):7421.
-
RNA interacts with topoisomerase I to adjust DNA topology. Mol Cell. 2024 Sep 05; 84(17):3192-3208.e11.
-
RBM10 Mutation as a Potential Negative Prognostic/Predictive Biomarker to Therapy in Non-Small-Cell Lung Cancer. Clin Lung Cancer. 2024 Dec; 25(8):e411-e419.
-
The Musashi-1-type 2 deiodinase pathway regulates astrocyte proliferation. J Biol Chem. 2024 Jul; 300(7):107477.
-
The debranching enzyme Dbr1 regulates lariat turnover and intron splicing. Nat Commun. 2024 May 30; 15(1):4617.